Krzystof Łabuzek

Summary

Affiliation: Medical University
Country: Poland

Publications

  1. ncbi request reprint Hypolipidemic drugs affect monocyte IL-1beta gene expression and release in patients with IIa and IIb dyslipidemia
    Boguslaw Okopien
    Department of Clinical Pharmacology, Medical University of Silesia, Katowice, Poland
    J Cardiovasc Pharmacol 45:160-4. 2005
  2. ncbi request reprint Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia
    Bogusław Okopień
    Department of Clinical Pharmacology, Medical University of Silesia, Medykow 18, PL 40 752 Katowice, Poland
    Pol J Pharmacol 56:781-7. 2004
  3. ncbi request reprint The risk of atherosclerosis in patients with impaired glucose tolerance
    B Okopien
    Department of Clinical Pharmacology, Medical University of Silesia, Medykow 18, 40 752 Katowice, Poland
    Res Commun Mol Pathol Pharmacol 113:87-95. 2003
  4. ncbi request reprint Monocyte suppressing action of fenofibrate
    Bogusław Okopień
    Department of Clinical Pharmacology, Medical University of Silesia, Medykow 18, PL 40 752 Katowice, Poland
    Pharmacol Rep 57:367-72. 2005
  5. ncbi request reprint [Proatherogenic lipid metabolism disturbances in impaired glucose tolerance]
    Bogusław Okopień
    Katedra Farmakologii, Zakład Farmakologii Klinicznej SI AM
    Pol Merkur Lekarski 18:219-22. 2005

Collaborators

  • Robert Krysiak
  • Bogusław Okopień
  • Marek Zielinski
  • Aldona Stachura-Kułach
  • Boguslaw Okopien
  • Andrzej Kułach
  • Andrzej Madej
  • Zbigniew S Herman
  • Dariusz Belowski
  • Jan Kowalski
  • B Okopien
  • Zbigniew Stanislaw Herman
  • Andrzej Kulach
  • Malgorzata Huzarska
  • Zbigniew Stanisław Herman
  • Aldona Stachura-Kulach
  • A Kulach
  • Z Kalina
  • M Wisniewska-Wanat
  • M Sierant
  • Z Stanislaw Herman
  • M Zielinski
  • J Kowalski
  • A Stachura-Kulach

Detail Information

Publications5

  1. ncbi request reprint Hypolipidemic drugs affect monocyte IL-1beta gene expression and release in patients with IIa and IIb dyslipidemia
    Boguslaw Okopien
    Department of Clinical Pharmacology, Medical University of Silesia, Katowice, Poland
    J Cardiovasc Pharmacol 45:160-4. 2005
    ..In conclusion, effective 1-month hypolipidemic therapy with atorvastatin or fenofibrate diminished plasma levels of proinflammatory and procoagulatory state markers...
  2. ncbi request reprint Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia
    Bogusław Okopień
    Department of Clinical Pharmacology, Medical University of Silesia, Medykow 18, PL 40 752 Katowice, Poland
    Pol J Pharmacol 56:781-7. 2004
    ..Our results support the findings about a relatively weak effect of statin therapy on plasma fibrinogen level and partially explain contradictory results of previous studies...
  3. ncbi request reprint The risk of atherosclerosis in patients with impaired glucose tolerance
    B Okopien
    Department of Clinical Pharmacology, Medical University of Silesia, Medykow 18, 40 752 Katowice, Poland
    Res Commun Mol Pathol Pharmacol 113:87-95. 2003
    ..Therefore the aim of this study is to evaluate the marker of the oxidation processes (oxLDL) as well as prothrombotic (PAI-1) and inflammatory state (MCP-1) markers in patients with Impaired Glucose Tolerance (IGT)...
  4. ncbi request reprint Monocyte suppressing action of fenofibrate
    Bogusław Okopień
    Department of Clinical Pharmacology, Medical University of Silesia, Medykow 18, PL 40 752 Katowice, Poland
    Pharmacol Rep 57:367-72. 2005
    ..9 vs. 14.0 +/- 0.8 ng/ml). The evaluated cytokines were markedly elevated in patients with type IIb dyslipidemia. Effective fenofibrate therapy had a significant inhibitory effect on the release of monocyte-derived inflammatory cytokines...
  5. ncbi request reprint [Proatherogenic lipid metabolism disturbances in impaired glucose tolerance]
    Bogusław Okopień
    Katedra Farmakologii, Zakład Farmakologii Klinicznej SI AM
    Pol Merkur Lekarski 18:219-22. 2005
    ....